Home / Science / New Nanoparticles Target Cancer's Copper Supply
New Nanoparticles Target Cancer's Copper Supply
17 Jul
Summary
- Nanoparticles deliver copper-binding agents to tumors.
- This strategy uses tumors' internal copper to kill cancer cells.
- The method avoids toxicity to healthy tissues.
A groundbreaking nanoparticle-based strategy has been developed to harness a tumor's own copper supply for cancer cell death. This innovative method focuses on cuproptosis, a cell death mechanism triggered by copper disruption.
The researchers engineered biodegradable nanoparticles, known for their safety, and equipped them with a tumor-penetrating peptide to target cancer cells. These nanoparticles carry TPEN, a compound that binds to copper ions.
Laboratory tests confirmed the targeted nanoparticles effectively delivered TPEN into cancer cells, showing significantly higher uptake than non-targeted versions. Crucially, the targeted approach demonstrated stronger toxicity against cancer cells while causing substantially less damage to healthy human cells.
This strategy of utilizing endogenous copper offers a promising path for enhancing selectivity and reducing systemic side effects common in metal-based cancer therapies. While scientifically promising, experts note that further research is required to ensure safety, identify responsive cancers, and establish reliable biomarkers for treatment efficacy.
